Pyomyositis is a severe bacterial infection of skeletal muscle, commonly affecting 35 children in tropical regions and predominantly caused by Staphylococcus aureus. To 36 understand the contribution of bacterial genomic factors to pyomyositis, we conducted a 37 genome-wide association study of S. aureus cultured from 101 children with pyomyositis and 38 417 children with asymptomatic nasal carriage attending the Angkor Hospital for Children in 39 Cambodia. We found a strong relationship between bacterial genetic variation and pyomyositis, 40 with estimated heritability 63.8% (95% CI 49.2-78.4%). The presence of the Panton-Valentine 41 leucocidin (PVL) locus increased the odds of pyomyositis 130-fold (p=10 -17.9 ). The signal of 42 association mapped both to the PVL-coding sequence and the sequence immediately upstream. 43 Together these regions explained >99.9% of heritability. Our results establish staphylococcal 44 pyomyositis, like tetanus and diphtheria, as critically dependent on expression of a single toxin 45 and demonstrate the potential for association studies to identify specific bacterial genes 46 promoting severe human disease. 47 48 49
Introduction 50
Microbial genome sequencing and bacterial genome-wide association studies present new 51 opportunities to discover bacterial genes involved in the pathogenesis of serious infections. 1-6 52 Pyomyositis is a severe infection of skeletal muscle most commonly seen in children in the 53 tropics. [7] [8] [9] In up to 90% of cases it is caused by a single bacterial pathogen, Staphylococcus 54 aureus. [7] [8] [9] [10] There is evidence that some S. aureus strains have heightened propensity to cause 55 pyomyositis -the incidence in the USA doubled during an epidemic of community-associated 56 methicillin resistant S. aureus (CA-MRSA) 11 -but molecular genetic investigation of S. aureus 57 from pyomyositis has been limited. 12 58 Panton-Valentine leucocidin (PVL), a well-known staphylococcal toxin causing purulent skin 59 infections and found in epidemics caused by CA-MRSA, has been implicated in pyomyositis, 60 pneumonia and other S. aureus disease manifestations, but its role is strongly disputed. 13-16 61 PVL is a bipartite pore-forming toxin comprising the co-expressed LukF-PV and LukS-PV 62 proteins, 17,18 is encoded by lukSF-PV, which is usually carried on bacteriophages 13,17 which 63
facilitates lukSF-PV exchange between lineages. 19 Although small case series testing for 64 candidate genes have reported a high prevalence of PVL among pyomyositis-causing 65 S. aureus, 11,20,21 a detailed meta-analysis found no evidence for an increased rate of 66 musculoskeletal infection or other invasive disease in PVL-positive bacteria versus controls. 13 67
These conflicting results may reflect insufficiently powered studies. However, candidate gene 68 studies may also miss important variation elsewhere in the genome: a study claiming a critical 69 role for PVL in the causation of severe pneumonia 15 was later found to have overlooked 70 mutations in key regulatory genes, capable of producing the virulent behaviour that had been 71 attributed to PVL by the original study. 16 Thus, based on the current evidence, opinion is 72 divided as to whether PVL is an important virulence factor in pyomyositis, or merely an 73 epiphenomenon, carried by bacteria alongside unidentified genetic determinants. 22,23 74
Genome-wide association studies (GWAS) offer a means to screen entire bacterial genomes to 75 discover genes and genetic variants associated with disease risk. They are particularly 76 appealing because they enable the investigation of traits not readily studied in the laboratory, 77
and do not require the nomination of specific candidate genes. 5 Proof-of-principle GWAS in 78 bacteria have already demonstrated the ability to successfully rediscover known antimicrobial 79 resistance (AMR) determinants. 2,3,4 However, AMR is under extraordinarily intense selection in 80 bacteria, and it remains to be seen whether GWAS can overcome the typically strong linkage 81 disequilibrium in bacterial populations to precisely pinpoint genes and genetic variants 82
underlying the propensity to cause human infection. 83
Results

84
To understand the bacterial genetic basis of pyomyositis, we sampled and whole-genome 85 sequenced S. aureus from 101 pyomyositis infections and 417 asymptomatic nasal carriage 86 episodes in 518 children attending Angkor Hospital for Children in Siem Reap, Cambodia 87 between 2008 and 2012 (Table S1 ). As expected of S. aureus epidemiology, we observed 88 representatives of multiple globally common lineages in Cambodia, together with some 89 globally less common lineages at high frequency, in particular clonal complex (CC) 121, 90
identified by Multi-locus sequence type (MLST). Lineage composition appeared stable over 91 time, with no major changes in lineage frequency ( Fig. S1 ). 92
In our study, some S. aureus lineages were strongly overrepresented among cases of 93 pyomyositis compared to their frequency among asymptomatic, nasally-carried controls over 94 the same time period. Notably, 86/101 (85%) of pyomyositis cases were caused by CC-121 95 bacteria, whereas no pyomyositis cases were caused by the next two most commonly carried 96 lineages, sequence type (ST)-834 and CC-45 ( Fig. 1) . We estimated the overall heritability of 97 case/control status to be 63.8% (95% CI 49.2-78.4%) in the sample, reflecting the strong 98 relationship between bacterial genetic variation and case/control status. We used bugwas 6 to 99 decompose this heritability into the principal components (PCs) of bacterial genetic variation. 100 PC 1, which distinguished CC-121 (the most common pyomyositis lineage) from ST-834 101
(which was only found in carriage), showed the strongest association with case /control status 102 (p = 10 -29.6 , Wald test). The next strongest were PC 20, which differentiated a sub-lineage of 103 CC-121 within which no cases were seen (p = 10 -13.9 ), and PC 2, which distinguished CC-45 104 from the rest of the species (p =10 -4.9 ). 105
We conducted a GWAS to identify bacterial genetic variants associated with pyomyositis, 106 controlling for differences in pyomyositis prevalence between S. aureus lineages. We used a 107
kmer-based approach 1 in which every variably present 31bp DNA sequence observed among 108 the 518 genomes was tested for association with pyomyositis versus asymptomatic nasal 109 carriage, controlling for population structure using GEMMA. 24 These kmers captured bacterial 110 genetic variation including single nucleotide polymorphisms (SNPs), insertions or deletions 111 (indels), and presence or absence of entire accessory genes. We found 10.7 million unique 112 kmers variably present across the bacterial genomes. In total, 9,175 kmers were significantly 113 associated with case/control status after correction for multiple testing (10 -6.8 £ p £ 10 -21.4 ; Fig  114  2A ). The vast majority of these kmers (8,993/9,175; 98.0%) localised to a 45.7kb region 115
spanning an integrated prophage with 95% nucleotide similarity to jSLT ( Fig 2B) . Most 116 significant kmers, (9,173/9,175; 99.98%) were found more frequently in pyomyositis, with 117 odds ratios (OR) ranging from 2.7 to 139.8, indicating they were associated with increased risk 118 of disease. The bacteriophage jSLT was thus strongly associated with pyomyositis. 119
We were able to fine-map the signal of association within jSLT to the lukS-PV and lukF-PV 120 cargo genes. These genes encode the subunits of PVL, which multimerise into a pore-forming 121 toxin capable of rapidly lysing the membranes of human neutrophils, the first line of defense 122 against S. aureus. 17,25 1630 kmers tagging the presence of the lukSF-PV coding sequences 123 (CDS) were highly significantly associated with disease, being present in 98/101 (97%) 124 pyomyositis cases and 84/417 (20%) carriage controls (OR 129.5, ). Kmers tagging 125 variation in the 389bp region immediately upstream of the CDS were also strongly associated 126 with disease (p=10 -21.4 ). The most significant of these kmers were co-present with the CDS in 127 the same cases (98/101, 97.0%), but present in fewer controls (79/417, 18.9%), producing an 128 OR of 140. 129
Closer examination of this ~400bp upstream region in genomes assembled from short-read 130
Illumina sequencing showed that assembly of the region was problematic, with breaks or gaps 131 in the assembly (Fig. S2 ). To improve the accuracy of this region of the assembled genomes we 132 performed long-read Oxford Nanopore sequencing on the 37 genomes with incomplete or 133 discontinuous assembly upstream of the PVL CDS. By integrating long-read and short-read 134 data we were able to assemble a single contig spanning this region in all isolates ( Fig. S3 ). 135
When these improved assemblies were introduced, the signal of association upstream of the 136 PVL CDS was no more significant than within the CDS ( Fig 2C) . Therefore, the presence of 137 genomic sequence spanning the PVL toxin-coding sequences and the upstream, presumed 138 regulatory, region exhibited the strongest association with pyomyositis in the S. aureus 139 genome. 140
Presence or absence of the PVL region accounted for the differences in pyomyositis rates 141 between lineages. It was common in pyomyositis-associated lineages including CC-121 and 142 absent from non-pyomyositis-associated lineages including ST-834 and CC-45 ( Fig. 1 In this study we found a strong association between pyomyositis, a highly distinctive tropical 152 infection of skeletal muscle in children, and Panton-Valentine leukocidin, a bacterial toxin 153 commonly carried by bacteriophages. We found that a single coding region together with the 154 upstream sequence are all but necessary for the development of pyomyositis: its sporadic 155
presence is associated with pyomyositis in otherwise low-frequency strains, and its absence is 156 associated with asymptomatic carriage in a high propensity strain. The locally common PVL-157 positive CC-121 lineage contributes most strongly to the prevalence of pyomyositis in 158
Cambodian children. 159
While PVL has long been thought an important S. aureus virulence factor, 25, 26, 27 its role in 160 invasive disease has been controversial, 22,23 with conflicting results in case-control studies and 161
an absence of supporting evidence on meta-analysis. 13 In previous studies the PVL positive 162
USA300 lineage was associated with musculoskeletal infection (both pyomyositis and 163 osteomyelitis), however in these studies almost all these infections were caused by the USA300 164 strain, so the role of PVL was almost completely confounded by both methicillin resistance and 165 strain background. 11, 26 In our study, this confounding is broken down by the movement of PVL 166 on mobile genetic elements (MGEs). Here, despite the emergence of CA-MRSA in carriage in 167 the same population, 28 all the pyomyositis cases were MSSA. By applying GWAS methods to a 168 well-powered cohort, our study resolves the controversy around PVL and pyomyositis, 169
demonstrating strong heritability which localises to a single region, even when the full bacterial 170 genome is considered. This study offers empirical evidence that, in addition to elucidating 171 phenotypes under strong selection (such as in antimicrobial resistance) 2,3,4 , bacterial GWAS can 172 pinpoint variants when MGEs act to unravel linkage disequilibrium. 173
These results offer a novel prospect for disease prevention: they establish staphylococcal 174 pyomyositis as a disease whose pathogenesis depends critically on expression of a single toxin. 175
This property is shared by toxin-driven, vaccine-preventable diseases such as tetanus and 176 diphtheria. Therefore, vaccines that generate neutralising anti-toxin antibodies against PVL 29 177 may protect human populations against this common tropical disease. They also raise the 178 hypothesis that antibiotics which decrease toxin expression, and have been recommended in 179 some PVL-associated infections, 30 may offer specific clinical benefit in treating pyomyositis. 180
More generally, our study provides an example of how microbial GWAS can be used to 181 elucidate the pathogenesis of bacterial infections and identify specific virulence genes 182 associated with human disease. 183 Bonferroni-adjusted threshold for significance is plotted in grey (B) The region between 1.57-200
1.62 MB in greater detail. Gray arrows depict coding sequences, determined by homology to 201 USA300 FPR3757. (C) Associations for kmers mapping to region 1,571 -1,574kB is plotted. 202
Kmer presence determined from hybrid assembly using short and long-read data for assembly. 203
Gray arrows depict coding sequences, determined by homology to USA300 FPR3757. 204 205
Materials and Methods: 206
Patient sample collection. We retrospectively identified pyomyositis cases from the Angkor 207
Hospital for Children in Siem Reap, Cambodia, between January 2007 and November 2011. 208 We screened all attendances in children (≤16 years) using clinical coding (ICD-10 code M60 209 (myositis)) and isolation of S. aureus from skeletal muscle abscess pus. We reviewed clinical 210 notes to confirm a clinical diagnosis of pyomyositis was made by the medical staff, and 211 bacterial strains cultured by routine clinical microbiology laboratory were retrieved from the 212 local microbiology biobank. 106 clinical episodes of pyomyositis were identified, in 101 213 individuals, and we included the earliest episode from each individual. 214
We identified S. aureus nasal colonisation from two cohort studies undertaken at Angkor 215
Hospital for Children. The first were selected from a collection characterising nasal 216 colonization in the region between September and October, 2008, which has previously been 217 described using multi-locus sequence typing. 28 The swabs had been saved at -80°C since the 218 study, these samples were reexamined for the presence of S. aureus using selective agar, 219 confirmed using Staphaurex (Remel, Lenexa, USA) and the DNAse agar test (Oxoid, 220
Hampshire, UK). Antimicrobial susceptibility testing was performed according to the 2014 221
Clinical and Laboratory Standards Institute guidelines (M100-24). 31 222
We undertook a second cohort study in 2012. Inclusion criteria were children (≤16 years) 223
attending as an outpatient at Angkor Hospital for Children with informed consent. There were 224 no exclusion criteria. Children were swabbed between the 2-7th July 2012, using sterile cotton 225 tipped swabs pre-moistened (with phosphate buffered saline, PBS) using 3 full rotations of the 226 swab within the anterior portion of each nostril with one swab being used for both nostrils, the 227 ends were broken into bottles containing sterile PBS and kept cool until plated in the laboratory 228 (within the hour). The swabs were plated onto Mannitol Salt agar to select for S. aureus. The 229 M100-24 CLSI 31 standards were followed for susceptibility testing and bacteria stored in 230 tryptone soya broth and glycerol at -80°C. 231
We selected controls from carriers in these two cohorts using the excel randomization function: 232 222 of 519 from the 2008 cohort and 195 of 261 from the 2012 cohort. 233 Ethical Framework. Approval for this study was provided by the AHC institutional review 234 board and the Oxford Tropical Ethics Committee (507-12). 235
Whole genome sequencing. For each bacterial culture, a single colony was sub-cultured and 236 DNA was extracted from the sub-cultured plate using a mechanical lysis step (FastPrep;  237 MPBiomedicals, Santa Ana, CA) followed by a commercial kit (QuickGene; Autogen Inc, 238
Holliston, MA), and sequenced at the Wellcome Trust Centre for Human Genetics, Oxford on 239 the Illumina (San Diego, California, USA) HiSeq 2500 platform, with paired-end reads 150 240 base pairs long. 241 A subset of samples were sequenced using long-read sequencing technology. We selected 37 242
isolates with incomplete assembly upstream of the PVL locus, 22 with ambiguous base calls in 243 the assembly, and 15 where the region was assembled over 2 contigs. DNA was extracted using 244
Genomic Tip 100/G (Qiagen, Manchester, UK) and DNA libraries prepared using Oxford 245 Nanopore Technologies (ONT) SQK-LSK108 library kit (ONT, Oxford, UK) according to 246 manufacturer instructions. These were then sequenced on ONT GridION device integrated with 247 a FLO-MIN106 flow cell (ONT, Oxford, UK). ONT base calling was performed using Guppy 248 v.1.6. 249
Variant calling. For short-read sequencing we used Velvet 32 v1.0.18 to assemble reads into 250 contigs de novo. Velvet Optimiser v2.1.7 was used to choose the kmer lengths on a per 251 sequence basis. The median kmer length was 123bp (IQR 119-123). To obtain multilocus 252 sequence types we used BLAST 33 to find the relevant loci, and looked up the nucleotide 253 sequences in the online database at http://saureus.mlst.net/. Strains that shared 6 of 7 MLST 254 loci were considered to be in the same Clonal Complex. Antibiotic sensitivity was predicted by 255
interrogating the assemblies for a panel of resistance determinants as previously described. 34 256
We used Stampy 35 v1.0.22 to map reads against reference genomes (USA300_FPR3757,  257 Genbank accession number CP000255.1). 36 Repetitive regions, defined by BLAST 33 258 comparison of the reference genome against itself, were masked prior to variant calling. Bases 259 were called at each position using previously described quality filters. 37-39 260
After filtering ONT reads with filtlong v.0.2.0 (with settings filtlong --min_length 1000 --261 keep_percent 90 --target_bases 500000000 --trim --split 500), hybrid assembly of short 262
(Illumina) and long (ONT) reads were made, using Unicycler v0.4.5 40 (default settings). The 263
workflow for these assemblies is available at 264 https://gitlab.com/ModernisingMedicalMicrobiology/MOHAWK) 265
Reconstructing the phylogenetic tree. We constructed a maximum likelihood phylogeny of 266 mapped genomes for visualization using RAxML 41 assuming a general time reversible (GTR) 267 model. To overcome a limitation in the presence of divergent sequences whereby RAxML fixes 268 a minimum branch length that may be longer than a single substitution event, we fine-tuned the 269 estimates of branch lengths using ClonalFrameML. 42 270 Kmer counting. We used a kmer-based approach to capture non-SNP variation. 1 Using the de 271
novo assembled genome, all unique 31 base haplotypes were counted using dsk 43 . If a kmer 272 was found in the assembly it was counted present for that genome, otherwise it was treated as 273 absent. This produced a set of 10,744,013 variably present kmers, with the presence or absence 274 of each determined per isolate. We identified a median of 2,801,000 kmers per isolate, 275
including variably present kmers and kmers common to all genomes (IQR 2,778,000-276 2,837,000). 277
Calculating heritability. We used the Genome-wide Efficient Mixed Model Association tool 278 (GEMMA 24 ) to fit a univariate linear mixed model for association between a single phenotype 279 (pyomyositis vs asymptomatic nasal carriage). We calculated the relatedness matrix from 280 kmers, and used GEMMA to estimate the proportion of variance in phenotypes explained by 281 genotypic diversity (i.e. heritability). 282
Genome wide association testing of Kmers. We performed association testing using an R 283 package bacterialGWAS (https://github.com/jessiewu/bacterialGWAS), which implements a 284
published method for locus testing in bacterial GWAS. 3 The association of each kmer on the 285 phenotype was tested, controlling for the population structure and genetic background using a 286 linear mixed model (LMM) implemented in GEMMA. 24 The parameters of the linear mixed 287 model were estimated by maximum likelihood and likelihood ratio test was performed against 288 the null hypothesis (that each locus has no effect) using the software GEMMA. 24 GEMMA was 289 run using a minor allele frequency of 0 to include all SNPs. GEMMA was modified to output 290 the ML log-likelihood under the null, and alternative and -log 10 p values were calculated using 291 R scripts in the bacterialGWAS package. Unadjusted odds ratios were reported because there 292 was no residual heritability unexplained by the most significant kmers. 293
Testing for lineage effects. We tested for associations between lineage and phenotype using an 294 R package bugwas (available at https://github.com/sgearle/bugwas), which implements a 295 published method for lineage testing in bacterial GWAS. 3 We tested lineages using principal 296 components. These were computed based on biallelic SNPs using the R function prcomp. To 297 test the null hypothesis of no background effect of each principal component, we used a Wald 298 test, which we compared against a χ 2 distribution with one degree of freedom to obtain a p 299 value. 300
Kmer mapping. We used Bowtie 44 to align all 31bp kmers from short-read sequencing were to 301 a draft reference (the de novo assembly of a CC-121 pyomyosits strain PYO2134). Areas of 302 homology between the draft reference and well-annotated reference strains were identified by 303 aligning sequences with Mauve 45 . For all 31bp kmers with significant association with case-304 controls status, the likely origin of the kmer was determined by nucleotide sequence BLAST 33 305 of the kmers against a database of all S. aureus sequences in Genbank. 306 Joint short-read and long-read analysis. 31bp kmers were counted for the 37 hybrid short-read 307 and long-read assemblies using dsk 43 . The presence or absence of all Illumina (short-read) 308
kmers that mapped to the two PVL toxin-coding sequences and the upstream intergenic region 309 plus the surrounding 1kb were reassessed. For the 37 samples with hybrid assemblies, the 310 presence/absence of these kmers was determined from the kmers counted from the hybrid 311 assemblies. For all other samples, presence/absence was determined from the kmers counted 312 from the short-read only assemblies. The new presence/absence patterns were tested for 313 association with the phenotype controlling for population structure and genetic background 314 using GEMMA 24 , using the same relatedness matrix as the original short-read analysis. 315
Multiple testing correction. Multiple testing was accounted for by applying a Bonferroni 316 correction; 46 the individual locus effect of a variant (kmer or PC) was considered significant if 317 its P value was smaller than α/n p , where we took α = 0.05 to be the genome-wide false-positive 318 rate and n p to be the number of kmers or PCs with unique phylogenetic patterns, that is, unique 319 partitions of individuals according to allele membership. We identified 236627 unique kmer 320 patterns and 518 PCs, giving thresholds of 2.1 x10 -7 and 9.7x10 -5 respectively. 321 Data availability. Sequence data has been submitted to Short Read Archive (Bioproject ID 322 PRJNA418899). 323 324 325
500
Figure S2 Alignments of reference genome PYO2134 assembly (R) with 37 de novo assemblies of Illumina short-read sequencing (C) which 501 feature either ambiguities (Ns) or contig boundaries in the region 389bp upstream of PVL coding sequence. Contig boundaries, when 502 overlapping, are marked with a red diamond. Ns in the assembly are marked in dark grey. Polymorphisms are colour-coded by base. 503 17 504
Figure S3
Alignments of reference genome PYO2134 assembly (R) with 37 de novo hybrid assemblies combining Oxford Nanopore long-read 505
and Illumina short-read sequencing (C) which featured ambiguities (Ns) or hybrid assembly contig boundaries in the region 389bp upstream of 506 PVL coding sequence in the Illumina short-read only assemblies. All ambiguities and contig boundaries are resolved in the hybrid assemblies. 507 Table S1 . Isolates included in this study. 509 Table S2 : All significant kmers from short read sequencing assembly, evidence of 510 association, frequency and best match on blastn to all S. aureus sequences in Genbank. 511
